General Partner Inc’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$485K Hold
6,199
0.26% 65
2026
Q1
$537K Hold
6,199
0.33% 52
2025
Q4
$595K Hold
6,199
0.34% 53
2025
Q3
$590K Hold
6,199
0.33% 55
2025
Q2
$540K Hold
6,199
0.32% 54
2025
Q1
$557K Hold
6,199
0.36% 51
2024
Q4
$495K Sell
6,199
-58
-0.9% -$5.02K 0.3% 54
2024
Q3
$563K Hold
6,257
0.35% 52
2024
Q2
$492K Buy
6,257
+59
+1% +$4.84K 0.31% 54
2024
Q1
$540K Hold
6,198
0.34% 55
2023
Q4
$513K Hold
6,198
0.43% 44
2023
Q3
$472K Sell
6,198
-1,250
-17% -$105K 0.42% 43
2023
Q2
$656K Hold
7,448
0.55% 37
2023
Q1
$598K Buy
7,448
+58
+0.8% +$4.73K 0.53% 38
2022
Q4
$574K Buy
+7,390
New +$599K 0.53% 37

Other funds holding MDT

General Partner Inc's MDT Position: Q2 2026 in Review

General Partner Inc held its Medtronic (MDT) position steady in Q2 2026 at 6,199 shares worth $485K. The position accounts for 0.26% of the portfolio, ranked #65.

General Partner Inc first reported a position in MDT in Q4 2022 and has held it in 15 quarters since. The position peaked at $656K in Q2 2023. 372 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • General Partner Inc held 6,199 shares of Medtronic worth $485K as of Q2 2026.
  • General Partner Inc left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.26% of General Partner Inc's portfolio in Q2 2026, its #65 holding.
  • General Partner Inc first reported a position in Medtronic in Q4 2022 and has held it in 15 quarters since.
  • General Partner Inc's Medtronic position peaked at $656K in Q2 2023.
  • 372 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on General Partner Inc's 13F filing for Q2 2026, filed 6 Jul 2026.